R. Scott Bitner,Kaitlin E. Browman,Michael E. Brune,Steven Fung,Peer B. Jacobson,Lynne E. Rueter,Marina I. Strakhova,Jiahong Wang,Jyoti R. Patel,Qi Shuai,James T. Link,Jeffrey J. Rohde,Jurgen Dinges,B
申请号：
US14226615
公开号：
US09290444B2
申请日:
2014.03.26
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.
